Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens

Rhea-AI Summary

Enovis (NYSE:ENOV) launched the DonJoy Spinamic Hybrid Scoliosis Brace, a first-of-its-kind hybrid device for adolescent idiopathic scoliosis. It combines rigid corrective elements with a breathable, adjustable vest to support in-brace curve correction while aiming to improve comfort and compliance.

Spinamic, supported by published clinical evidence for preventing curve progression in AIS, uses an adjustable three-point pressure system and comes in 10 off-the-shelf sizes. It allows fitting, in-brace X-ray, and adjustment in a single visit. The brace is now available in the United States, with regulatory clearance being pursued globally.

Positive

• Launch of Spinamic hybrid scoliosis brace for adolescent idiopathic scoliosis in the U.S.
• Device design supported by published clinical evidence in preventing curve progression in AIS
• Hybrid construction combines rigid corrective elements with breathable mesh for wearability
• Available in 10 off-the-shelf sizes with adjustable three-point pressure system
• Enables fitting, in-brace X-ray, and adjustment during a single clinical visit

Negative

• Current commercial availability limited to the United States pending further regulatory clearances

News Market Reaction – ENOV

-0.42%

-0.42% Session close to close

In the Jun 8 session, ENOV declined 0.42%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement introduces the Spinamic Hybrid Scoliosis Brace, targeting adolescent idiopathic sc...

Analysis

This announcement introduces the Spinamic Hybrid Scoliosis Brace, targeting adolescent idiopathic scoliosis, which affects 0.5%–5% of adolescents worldwide. The device blends rigid corrective elements with a breathable, adjustable design and an in-clinic, single-visit fitting workflow. In the context of recent revenue growth and reiterated 2026 guidance, the launch extends Enovis’ prevention and recovery portfolio. Investors may watch for clinical adoption indicators, geographic regulatory clearances, and how this product contributes to segment performance over time.

Key Figures

AIS prevalence: 0.5%–5% Brace sizes: 10 sizes Pressure system: Three-point +1 more

4 metrics

AIS prevalence 0.5%–5% Share of adolescents worldwide affected by adolescent idiopathic scoliosis

Brace sizes 10 sizes Off-the-shelf sizes available for Spinamic Hybrid Scoliosis Brace

Pressure system Three-point Adjustable three-point pressure system for curve correction and fit

Patient group Children and teens Target population with adolescent idiopathic scoliosis (AIS)

Historical Context

5 past events · Latest: May 07 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 07	Q1 2026 earnings	Positive	+9.7%	Reported Q1 2026 sales growth and reaffirmed full-year revenue and EBITDA guidance.
May 01	Portfolio company news	Neutral	+0.8%	Announcement related to public health–focused Knoa Pharma operations launch.
Apr 10	Earnings call notice	Neutral	+1.8%	Scheduled Q1 2026 earnings conference call and webcast details for investors.
Feb 26	FY 2025 earnings	Neutral	+13.9%	Reported Q4 and full-year 2025 results including goodwill impairment and 2026 guidance.
Feb 26	FY 2025 earnings	Neutral	+13.9%	Detailed full-year 2025 sales, impairment-driven net losses, and 2026 outlook metrics.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news, especially earnings and corporate updates, has frequently coincided with positive next-day price moves for ENOV.

Recent Company History

Over the last several months, Enovis has reported steady top-line growth with Q4 2025 net sales of $576 million and full-year 2025 sales of $2.2 billion, followed by Q1 2026 net sales of $589 million. Despite net losses driven in part by a $1.05 billion goodwill impairment, the company has consistently reiterated 2026 guidance for revenue of $2.31–2.37 billion and adjusted EBITDA of $425–435 million. Those earnings releases on Feb 26, 2026 and May 7, 2026 were followed by strong positive price reactions, framing today’s scoliosis-brace launch within an ongoing growth and product-innovation narrative.

Key Terms

adolescent idiopathic scoliosis, rigid bracing, dynamic braces, derotation

4 terms

adolescent idiopathic scoliosis medical

"preventing curve progression in adolescent idiopathic scoliosis1(AIS), Spinamic rethinks"

A spinal condition in which a child or teenager develops a sideways curvature of the backbone with no identifiable cause, often noticed during growth spurts. It matters to investors because it drives demand for diagnostic tools, braces, surgical devices and related therapies; like a leaning stack of blocks that may need monitoring or correction, the condition can create steady market opportunity in pediatric orthopedics and medical devices.

rigid bracing medical

"For decades, rigid bracing during skeletal growth has been the standard of care"

Rigid bracing is a stiff external support device, usually made from hard plastic, metal, or composite materials, worn around a joint or the spine to limit motion and hold bones or soft tissues in place while they heal. Investors care because sales, pricing and regulatory approval of these devices affect revenue and margins for medical-device companies; think of a rigid brace as a safety scaffold whose market size and reimbursement rules influence manufacturers’ financial outlooks.

dynamic braces medical

"Flexible or "dynamic" braces offer improved comfort and mobility"

Dynamic braces are medical-support devices that stabilize a joint or limb while permitting controlled movement, using hinges, springs, straps or elastic elements to guide motion and reduce stress on tissues. For investors, they matter because they can improve recovery outcomes and patient comfort compared with rigid braces, which affects clinical adoption, reimbursement, pricing and sales potential for companies that design, manufacture or sell them — similar to how a car’s adaptive suspension can command a premium by improving ride and handling.

derotation medical

"hump pad is placed at the base of the rib prominence to aid in derotation of"

Derotation is a medical procedure that straightens or untwists a body part that has rotated out of its normal position, such as a twisted bone or misaligned eye muscle; think of turning a stuck knob back to its correct orientation. For investors, derotation matters because it defines a clear clinical need, influences the size of the customer and reimbursement market, affects the complexity and cost of trials and devices, and helps gauge regulatory and adoption risks for related medical products.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

The DonJoy Spinamic® Hybrid Scoliosis Brace is a first-of-its-kind device that integrates rigid corrective elements into a breathable, adjustable design to improve both clinical outcomes and patient compliance in adolescent idiopathic scoliosis

• Spinamic combines the curve-correction efficacy of rigid bracing with the comfort and mobility of dynamic braces, offering an optimal balance of therapy and patient wearability
  
  
• Available in 10 off-the-shelf sizes with an adjustable three-point pressure system, the brace enables fitting, imaging, and adjustment in a single visit
  
  
• Spinamic is now available in the United States, with regulatory clearance being pursued across additional markets worldwide
  
  

DALLAS, TX, June 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, today announced the launch of the DonJoy Spinamic® Hybrid Scoliosis Brace, to be distributed by its subsidiary, DJO, LLC. Supported by published clinical evidence demonstrating effectiveness in preventing curve progression in adolescent idiopathic scoliosis¹(AIS), Spinamic rethinks traditional bracing by integrating dynamic support with structural control designed to provide in-brace correction while supporting improved wearability for children and teens with AIS.

A common spinal disorder in young people, AIS affects approximately 0.5% to 5% of adolescents worldwide.^2,3 For decades, rigid bracing during skeletal growth has been the standard of care to prevent curve progression, but it often comes at a significant cost to the patient.⁴ Rigid braces may irritate skin, heighten stress, and lower self-esteem; for some adolescents, the psychological and physical burden leads them to stop wearing braces at all, preventing the overall clinical benefit.⁵ Flexible or "dynamic" braces offer improved comfort and mobility, but current evidence suggests they are less effective than well-designed rigid braces at controlling curve progression in AIS.⁶ Spinamic aims for the optimal balance of both approaches, with a hybrid design that integrates rigid corrective elements into a breathable mesh vest, using an adjustable three-point pressure system to maintain corrective forces while improving comfort and wearability, aiming to give adolescents a brace with which they can actually live.¹

“By combining the corrective strength of a rigid brace with the flexibility and mobility of a dynamic solution, Spinamic helps eliminate the tradeoff scoliosis patients often face between effective treatment and maintaining their quality of life,” said Terry Ross, President of Enovis’ Prevention & Recovery business segment. “This launch reflects Enovis’ broader commitment to delivering innovative solutions that support patients across the full continuum of care and throughout every stage of their journey.”

Available in 10 sizes, Spinamic is not only designed for effectiveness, comfort, and patient compliance, but also for more streamlined patient visits and efficient clinical workflows. Adolescents can be fitted, have an in-brace X-ray taken, and receive any necessary adjustments, all in a single visit without the need to wait weeks for a brace to be made. Pressure regulators mounted to adjustable rail-type pressure plates may be positioned to align to the apex of most curve types, while an adjustable hump pad is placed at the base of the rib prominence to aid in derotation of the scoliotic curve as treatment progresses. The brace's cool air mesh fabric is breathable, hand-washable, and designed to be easy to put on, take off, and wear for extended periods.

Spinamic is now available in the United States. Enovis is pursuing regulatory clearance worldwide. For more information, click here.

About Enovis
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com.

Trademark Notice
Spinamic® is a registered trademark of Value & Trust Company, Ltd.

Media Contact
Cristina Pasquino
Enovis Corporation
Cristina.Pasquino@enovis.com

References

---

¹ Kim H, et al. The efficacy of a novel hybrid brace in the treatment of adolescent idiopathic scoliosis: a prospective case-series study. Children. 2025;12(3):328.
² Menger RP, Sin AH. Adolescent idiopathic scoliosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026. Updated April 3, 2023. Accessed May 26, 2026.
³ Tu Q, Xu W, Feng Y, Zhang Z, Zhuang W. Prevalence and determinants of adolescent idiopathic scoliosis from school screening in Xiaoshan District, Hangzhou, China. Front Public Health. 2025;13:1595793. doi:10.3389/fpubh.2025.1595793
⁴ Dolan LA, Weinstein SL, Dobbs MB, et al. BrAIST-Calc: prediction of individualized benefit from bracing for adolescent idiopathic scoliosis. Spine (Phila Pa 1976). 2024;49(3):147-156. doi:10.1097/BRS.0000000000004879.
⁵ CLEAR Scoliosis Institute. Side effects of scoliosis treatment. CLEAR Scoliosis Institute. Updated April 16, 2021. Accessed May 26, 2026. https://clear-institute.org/treating-scoliosis/side-effects-of-scoliosis-treatment/.
⁶ Weiss HR, Çolak TK, Lay M, Borysov M. Brace treatment for patients with scoliosis: state of the art. S Afr J Physiother. 2021;77(2):1573. doi:10.4102/sajp.v77i2.1573.

Attachment

• DonJoy Spinamic® Hybrid Scoliosis Brace

FAQ

What is the Spinamic Hybrid Scoliosis Brace launched by Enovis (NYSE:ENOV)?

The Spinamic Hybrid Scoliosis Brace is a DonJoy device for adolescent idiopathic scoliosis that combines rigid correction with a breathable, adjustable vest. According to Enovis, it integrates dynamic support and structural control to provide in-brace correction while aiming to improve comfort and wearability.

When did Enovis (ENOV) launch the DonJoy Spinamic Hybrid Scoliosis Brace?

Enovis launched the DonJoy Spinamic Hybrid Scoliosis Brace on June 8, 2026, in the United States. According to Enovis, the brace is now commercially available domestically, with regulatory clearance being pursued in additional international markets to expand access for adolescents with scoliosis.

How does the Enovis (ENOV) Spinamic Hybrid Scoliosis Brace help treat adolescent idiopathic scoliosis?

Spinamic helps treat adolescent idiopathic scoliosis by combining rigid corrective elements with a dynamic, breathable design to support in-brace curve correction. According to Enovis, an adjustable three-point pressure system maintains corrective forces while its mesh vest and hump pad aim to enhance comfort and wearability.

What clinical evidence supports the Spinamic Hybrid Scoliosis Brace from Enovis (ENOV)?

Spinamic is supported by published clinical evidence demonstrating effectiveness in preventing curve progression in adolescent idiopathic scoliosis. According to Enovis, this evidence underpins the brace’s hybrid approach, which integrates structural control and dynamic support to provide in-brace correction while aiming to improve patient compliance.

How does Spinamic from Enovis (NYSE:ENOV) impact scoliosis clinic workflows?

Spinamic can streamline scoliosis clinic workflows by enabling fitting, in-brace X-ray, and adjustment in a single visit. According to Enovis, its 10 off-the-shelf sizes and adjustable pressure plates reduce the need for custom fabrication and follow-up appointments for initial brace setup.

Where is the DonJoy Spinamic Hybrid Scoliosis Brace from Enovis (ENOV) available?

The DonJoy Spinamic Hybrid Scoliosis Brace is currently available in the United States for adolescents with scoliosis. According to Enovis, the company is actively pursuing regulatory clearance across additional markets worldwide to extend access to this hybrid bracing solution.